Search Results - "Hsu, Christine"

Refine Results
  1. 1

    Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology by Mederacke, Ingmar, Hsu, Christine C., Troeger, Juliane S., Huebener, Peter, Mu, Xueru, Dapito, Dianne H., Pradere, Jean-Philippe, Schwabe, Robert F.

    Published in Nature communications (2013)
    “…Although organ fibrosis causes significant morbidity and mortality in chronic diseases, the lack of detailed knowledge about specific cellular contributors…”
    Get full text
    Journal Article
  2. 2

    Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice by Troeger, Juliane S, Mederacke, Ingmar, Gwak, Geum–Youn, Dapito, Dianne H, Mu, Xueru, Hsu, Christine C, Pradere, Jean–Philippe, Friedman, Richard A, Schwabe, Robert F

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2012)
    “…Background & Aims Activated hepatic stellate cells (HSCs), the main fibrogenic cell type in the liver, undergo apoptosis after cessation of liver injury, which…”
    Get full text
    Journal Article
  3. 3

    Advances in understanding ischemic acute kidney injury by Munshi, Raj, Hsu, Christine, Himmelfarb, Jonathan

    Published in BMC medicine (02-02-2011)
    “…Acute kidney injury (AKI) is independently associated with increased morbidity and mortality. Ischemia is the leading cause of AKI, and short of supportive…”
    Get full text
    Journal Article
  4. 4

    One dose versus two doses of COVID‐19 vaccine for the prevention of breakthrough infections among people previously infected with SARS‐Cov‐2 by Guo, Fangjian, Adekanmbi, Victor, Hsu, Christine D., Polychronopoulou, Efstathia, Berenson, Abbey B.

    Published in Journal of medical virology (01-01-2024)
    “…Studies have suggested the effectiveness of COVID‐19 vaccines in preventing SARS‐CoV‐2 reinfection among those previously infected. However, it is not yet…”
    Get full text
    Journal Article
  5. 5

    Iron overload disorders by Hsu, Christine C., Senussi, Nizar H., Fertrin, Kleber Y., Kowdley, Kris V.

    Published in Hepatology communications (01-08-2022)
    “…Iron overload disorders represent a variety of conditions that lead to increased total body iron stores and resultant end‐organ damage. An elevated ferritin…”
    Get full text
    Journal Article
  6. 6

    Cervical cancer screening utilization among kidney transplant recipients, 2001-2018 by Hsu, Christine D, Yu, Xiaoying, Guo, Fangjian, Adekanmbi, Victor, Kuo, Yong-Fang, Westra, Jordan, Berenson, Abbey B

    “…Kidney transplant recipients (KTRs) have elevated risks of cervical pre-cancers and cancers, and guidelines recommend more frequent cervical cancer screening…”
    Get full text
    Journal Article
  7. 7

    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old by Hsu, Christine D., Wang, Xiaoyan, Habif, David V., Ma, Cynthia X., Johnson, Kimberly J.

    Published in Cancer (15-08-2017)
    “…BACKGROUND Few population‐based studies have examined the association between health insurance status and breast cancer stage at diagnosis and survival. The…”
    Get full text
    Journal Article
  8. 8

    Polypharmacy and Incident Frailty in a Longitudinal Community‐Based Cohort Study by Shmuel, Shahar, Lund, Jennifer L., Alvarez, Carolina, Hsu, Christine D., Palta, Priya, Kucharska‐Newton, Anna, Jordan, Joanne M., Nelson, Amanda E., Golightly, Yvonne M.

    “…OBJECTIVES Polypharmacy may affect frailty, a common and costly condition among older adults. Frailty prevalence is elevated among racial/ethnic minorities and…”
    Get full text
    Journal Article
  9. 9

    Prenatal Risk Factors for Childhood CKD by HSU, Christine W, YAMAMOTO, Kalani T, HENRY, Rohan K, DE ROOS, Anneclaire J, FLYNN, Joseph T

    “…Development of CKD may be programmed prenatally. We sought to determine the association of childhood CKD with prenatal risk factors, including birth weight,…”
    Get full text
    Journal Article
  10. 10

    Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease by Hsu, Christine C, Ness, Erik, Kowdley, Kris V

    Published in Advances in nutrition (Bethesda, Md.) (01-03-2017)
    “…Nonalcoholic fatty liver disease (NAFLD) can range in spectrum from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which is characterized by…”
    Get full text
    Journal Article
  11. 11

    Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003–2014 by Hsu, Christine D., Nichols, Hazel B., Lund, Jennifer L.

    Published in Journal of cancer survivorship (01-06-2022)
    “…Purpose This study examines polypharmacy and prescription drug use patterns in cancer survivors, a growing population at risk for cancer sequelae and side…”
    Get full text
    Journal Article
  12. 12

    Trends in Cigarette Smoking Prevalence Among Refinery and Petrochemical Plant Workers, 1950 to 1999 by Hsu, Christine D, Momin, Fayaz, Hess, Judy Wendt, de Carvalho, Mary Freire

    “…OBJECTIVE:Smoking is a potential confounder in studies of workplace exposures and smoking-related disease, but little data exist to quantitatively adjust for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Risk factors for bleeding hepatocellular adenoma in a United States cohort by McDermott, Chelsea, Ertreo, Marco, Jha, Reena, Ko, Jimin, Fernandez, Stephen, Desale, Sameer, Fishbein, Thomas, Satoskar, Rohit, Winslow, Emily, Smith, Coleman, Hsu, Christine C

    Published in Liver international (01-01-2022)
    “…Background & Aims Known risk factors for hepatocellular adenoma (HCA) bleeding are size >5 cm, growth rate, visible vascularity, exophytic lesions, β‐catenin…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Incidence of human papillomavirus–related cancers among males and females aged 15-34 years in the United States by Guo, Fangjian, Adekanmbi, Victor, Hsu, Christine D, Berenson, Abbey B

    Published in JNCI cancer spectrum (01-03-2023)
    “…Abstract Postmarket surveillance of the incidence of human papillomavirus (HPV)–related cancers is essential to monitor the effectiveness of HPV vaccines. We…”
    Get full text
    Journal Article
  17. 17

    Incomplete HPV Vaccination among Individuals Aged 27-45 Years in the United States: A Mixed-Effect Analysis of Individual and Contextual Factors by Adekanmbi, Victor, Guo, Fangjian, Hsu, Christine D, Shan, Yong, Kuo, Yong-Fang, Berenson, Abbey B

    Published in Vaccines (Basel) (01-04-2023)
    “…In the United States, the human papillomavirus (HPV) vaccine is approved for use in individuals up to age 45. Individuals 15 years and older require three…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The Effects of Alcohol on Other Chronic Liver Diseases by Hsu, Christine C., MD, Kowdley, Kris V., MD

    Published in Clinics in liver disease (01-08-2016)
    “…Alcohol consumption is often a comorbid condition in other chronic liver diseases. It has been shown to act in synergy to increase liver injury in viral…”
    Get full text
    Journal Article
  20. 20

    Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports by Higley, Cory, Hsu, Christine C, Smith, Coleman, Nadella, Sandeep, Lalos, Alexander T

    Published in World journal of hepatology (27-12-2020)
    “…Direct-acting antiviral (DAA) therapy regimens are highly effective at eliminating hepatitis C virus (HCV) infection but rates of sustained virologic response…”
    Get full text
    Journal Article